McKesson (NYSE:MCK) Issues Q2 2025 Earnings Guidance

McKesson (NYSE:MCK) issued an update on its second quarter 2025 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 6.700-7.000 for the period, compared to the consensus estimate of 7.240. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several research firms have commented on MCK. Citigroup boosted their target price on McKesson from $620.00 to $670.00 and gave the stock a buy rating in a report on Friday, July 19th. Barclays upped their price target on shares of McKesson from $596.00 to $616.00 and gave the stock an overweight rating in a research note on Thursday, August 8th. Evercore ISI cut their price objective on shares of McKesson from $660.00 to $630.00 and set an outperform rating on the stock in a research report on Thursday, August 8th. Leerink Partners dropped their target price on shares of McKesson from $670.00 to $665.00 and set an outperform rating on the stock in a research note on Thursday. Finally, Robert W. Baird cut their price target on shares of McKesson from $694.00 to $671.00 and set an outperform rating on the stock in a report on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the company has an average rating of Moderate Buy and an average price target of $624.93.

McKesson Stock Down 2.1 %

Shares of NYSE:MCK opened at $504.17 on Friday. The stock has a market capitalization of $65.51 billion, a PE ratio of 22.53, a price-to-earnings-growth ratio of 1.29 and a beta of 0.44. The firm’s 50 day moving average price is $574.75 and its 200-day moving average price is $557.64. McKesson has a twelve month low of $412.64 and a twelve month high of $637.51.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, topping the consensus estimate of $7.21 by $0.67. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The business had revenue of $79.28 billion for the quarter, compared to analysts’ expectations of $82.53 billion. During the same quarter last year, the company posted $7.27 EPS. The company’s revenue was up 6.4% compared to the same quarter last year. Analysts expect that McKesson will post 32.14 earnings per share for the current fiscal year.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd will be paid a $0.71 dividend. The ex-dividend date is Friday, August 30th. This represents a $2.84 annualized dividend and a dividend yield of 0.56%. This is an increase from McKesson’s previous quarterly dividend of $0.62. McKesson’s dividend payout ratio (DPR) is 12.69%.

Insider Activity at McKesson

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction that occurred on Wednesday, July 3rd. The shares were sold at an average price of $580.92, for a total transaction of $2,180,192.76. Following the sale, the chief executive officer now owns 86,092 shares in the company, valued at approximately $50,012,564.64. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the stock in a transaction on Wednesday, July 3rd. The stock was sold at an average price of $580.92, for a total value of $2,180,192.76. Following the completion of the sale, the chief executive officer now owns 86,092 shares in the company, valued at approximately $50,012,564.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Leann B. Smith sold 600 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $585.53, for a total value of $351,318.00. Following the sale, the executive vice president now directly owns 2,022 shares in the company, valued at $1,183,941.66. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,859 shares of company stock worth $6,986,810. 0.11% of the stock is owned by company insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.